Precision Biosciences (DTIL) Total Liabilities (2018 - 2026)

Precision Biosciences (DTIL) has 9 years of Total Liabilities data on file, last reported at $67.8 million in Q1 2026.

• On a quarterly basis, Total Liabilities fell 9.7% year-over-year to $67.8 million in Q1 2026; TTM through Mar 2026 was $67.8 million, a 9.7% decrease from a year earlier, with the FY2025 full-year figure at $62.2 million, down 22.29% from the prior year.
• Total Liabilities for Q1 2026 stood at $67.8 million, up from $62.2 million in the prior quarter.
• Over the last five years, Total Liabilities for DTIL reached as high as $194.1 million in Q2 2022 and fell as low as $62.2 million in Q4 2025.
• Historically, Total Liabilities has averaged $119.0 million across 5 years, with a median of $111.7 million in 2022.
• Across the five-year window, Total Liabilities jumped 49.84% in 2022 and sank 49.11% in 2025, its largest moves.
• Year by year, Total Liabilities stood at $177.7 million in 2022, then retreated by 20.71% to $140.9 million in 2023, then sank by 43.23% to $80.0 million in 2024, then fell by 22.29% to $62.2 million in 2025, then advanced by 9.04% to $67.8 million in 2026.
• Per Business Quant data, the three most recent Total Liabilities figures were $67.8 million in Q1 2026, $62.2 million in Q4 2025, and $76.9 million in Q3 2025.